◆英語タイトル:Piramal Enterprises Ltd (PEL) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011267
◆発行会社(調査会社):
GlobalData
◆発行日:2017年12月22日
◆ページ数:39
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:インド
◆産業分野:医療機器
◆販売価格オプション(消費税別)
※
販売価格オプションの説明はこちらで、
ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※
GlobalData社の概要はこちらでご確認いただけます。
【レポートの概要】
Summary
Piramal Enterprises Ltd (PEL), is a provider of medicines and healthcare finance services. The company offers products such as Critical Care, Consumer Care, BST-CarGel, Phyto Medicines, Anaesthesias, Orthopedic medicines, Halothane, Isoflurane , Sevoflurane and other OTC related medicines. It also offers contract manufacturing and development services, pharma solutions, critical care solutions, imaging services, and other services such as fund management, structured investments and information management services. The company serves life sciences, financial services,health care, health care information management, specialty glass packaging and real estate sectors. It operates over 110 countries, including, India, Sri Lanka, Germany, Italy, the UK, France, Canada, the US and other countries. PEL is headquartered in Mumbai, Maharashtra, India.
Piramal Enterprises Ltd (PEL) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.
Scope
- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.
Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Piramal Enterprises Ltd, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Piramal Enterprises Ltd, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Piramal Enterprises Ltd, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Piramal Enterprises Ltd, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Piramal Enterprises Ltd, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Piramal Enterprises Ltd, Medical Equipment, Deal Details 10
Asset Purchase 10
Piramal Enterprises Acquires Digeplex and Associated Brands from Shreya Life Sciences 10
Piramal Healthcare Completes Acquisition Of Molecular Imaging Development Portfolio Of Bayer Pharma 11
Partnerships 12
Piramal Imaging Enters Into Licensing Agreement With Ci-Co Healthcare For Florbetaben F18 12
Piramal Imaging Enters into Partnership with Asan Medical 13
Piramal Enterprises Enters Into Co-Development Agreement With Tata Memorial Centre 14
IBA Molecular Enters Into Distribution Agreement With Piramal Imaging For 18F-Florbetaben 15
AC Immune Enters Into License Agreement With Piramal Imaging 16
Equity Offering 17
Piramal Enterprises Plans to Raise USD308 Million in Rights Offering of Shares 17
Piramal Enterprises Plans to Raise Funds through Public Offering 18
Piramal Enterprises Plans to Raise Up to USD774.6 Million in Issue of Securities 19
Debt Offering 20
Piramal Enterprises Raises USD770 Million in Private Placement of Debentures 20
Piramal Enterprises Raises USD51.6 Million in Private Placement of Debentures 21
Piramal Enterprises to Raise USD19.38 Million in Private Placement of Debentures 22
Asset Transactions 23
Smith & Nephew Acquires BST-CarGel from Piramal Healthcare 23
DiaSys Diagnostic Systems Acquires Diagnostics Division from Piramal Enterprises for USD2.12 Million 24
Acquisition 25
Piramal Enterprises Acquires Minority Stake in Health SuperHiway for USD0.1 Million 25
Third Avenue Management Acquires 1.26% Stake In Piramal Enterprises From Morgan Stanley For US$21 Million 26
Piramal Enterprises Ltd – Key Competitors 27
Piramal Enterprises Ltd – Key Employees 28
Piramal Enterprises Ltd – Locations And Subsidiaries 29
Head Office 29
Other Locations & Subsidiaries 29
Recent Developments 32
Strategy And Business Planning 32
Sep 28, 2016: Piramal plans to expand its API development & manufacturing capabilities at Digwal plant 32
Financial Announcements 33
Aug 01, 2016: Piramal Enterprises Consolidated Results for the First Quarter ended 30 June 2016 33
Feb 08, 2016: Piramal Enterprises Consolidated Results for the Q3 FY2016 and 9M FY2016 35
Corporate Communications 38
Mar 20, 2017: Piramal Pharma Solutions Names Stuart E. Needleman as Chief Commercial Officer 38
Appendix 39
Methodology 39
About GlobalData 39
Contact Us 39
Disclaimer 39
List of Tables
Piramal Enterprises Ltd, Medical Equipment, Key Facts, 2017 2
Piramal Enterprises Ltd, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Piramal Enterprises Ltd, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Piramal Enterprises Ltd, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Piramal Enterprises Ltd, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Piramal Enterprises Ltd, Deals By Market, 2011 to YTD 2017 8
Piramal Enterprises Ltd, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Piramal Enterprises Acquires Digeplex and Associated Brands from Shreya Life Sciences 10
Piramal Healthcare Completes Acquisition Of Molecular Imaging Development Portfolio Of Bayer Pharma 11
Piramal Imaging Enters Into Licensing Agreement With Ci-Co Healthcare For Florbetaben F18 12
Piramal Imaging Enters into Partnership with Asan Medical 13
Piramal Enterprises Enters Into Co-Development Agreement With Tata Memorial Centre 14
IBA Molecular Enters Into Distribution Agreement With Piramal Imaging For 18F-Florbetaben 15
AC Immune Enters Into License Agreement With Piramal Imaging 16
Piramal Enterprises Plans to Raise USD308 Million in Rights Offering of Shares 17
Piramal Enterprises Plans to Raise Funds through Public Offering 18
Piramal Enterprises Plans to Raise Up to USD774.6 Million in Issue of Securities 19
Piramal Enterprises Raises USD770 Million in Private Placement of Debentures 20
Piramal Enterprises Raises USD51.6 Million in Private Placement of Debentures 21
Piramal Enterprises to Raise USD19.38 Million in Private Placement of Debentures 22
Smith & Nephew Acquires BST-CarGel from Piramal Healthcare 23
DiaSys Diagnostic Systems Acquires Diagnostics Division from Piramal Enterprises for USD2.12 Million 24
Piramal Enterprises Acquires Minority Stake in Health SuperHiway for USD0.1 Million 25
Third Avenue Management Acquires 1.26% Stake In Piramal Enterprises From Morgan Stanley For US$21 Million 26
Piramal Enterprises Ltd, Key Competitors 27
Piramal Enterprises Ltd, Key Employees 28
Piramal Enterprises Ltd, Other Locations 29
Piramal Enterprises Ltd, Subsidiaries 29